These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 19933843)
21. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128 [TBL] [Abstract][Full Text] [Related]
22. Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats. Luo L; Lu AM; Wang Y; Hong A; Chen Y; Hu J; Li X; Qin ZH Exp Gerontol; 2013 Apr; 48(4):427-36. PubMed ID: 23419688 [TBL] [Abstract][Full Text] [Related]
23. Proliferation of murine c-kit(pos) cardiac stem cells stimulated with IGF-1 is associated with Akt-1 mediated phosphorylation and nuclear export of FoxO3a and its effect on downstream cell cycle regulators. Johnson AM; Kartha CC Growth Factors; 2014 Apr; 32(2):53-62. PubMed ID: 24580070 [TBL] [Abstract][Full Text] [Related]
24. FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Habashy HO; Rakha EA; Aleskandarany M; Ahmed MA; Green AR; Ellis IO; Powe DG Breast Cancer Res Treat; 2011 Aug; 129(1):11-21. PubMed ID: 21336599 [TBL] [Abstract][Full Text] [Related]
25. Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies. Marlow LA; von Roemeling CA; Cooper SJ; Zhang Y; Rohl SD; Arora S; Gonzales IM; Azorsa DO; Reddi HV; Tun HW; Döppler HR; Storz P; Smallridge RC; Copland JA J Cell Sci; 2012 Sep; 125(Pt 18):4253-63. PubMed ID: 22718346 [TBL] [Abstract][Full Text] [Related]
26. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression. Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451 [TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. Cascio S; Bartella V; Garofalo C; Russo A; Giordano A; Surmacz E J Biol Chem; 2007 Feb; 282(6):3498-506. PubMed ID: 17166846 [TBL] [Abstract][Full Text] [Related]
28. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
29. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis. Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998 [TBL] [Abstract][Full Text] [Related]
30. IGF-1-induced enhancement of PRNP expression depends on the negative regulation of transcription factor FOXO3a. Liu T; Yi W; Feng B; Zhou Z; Xiao G PLoS One; 2013; 8(8):e71896. PubMed ID: 23967259 [TBL] [Abstract][Full Text] [Related]
31. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Belguise K; Guo S; Sonenshein GE Cancer Res; 2007 Jun; 67(12):5763-70. PubMed ID: 17575143 [TBL] [Abstract][Full Text] [Related]
32. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. Belguise K; Sonenshein GE J Clin Invest; 2007 Dec; 117(12):4009-21. PubMed ID: 18037997 [TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells. Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090 [TBL] [Abstract][Full Text] [Related]
35. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells. Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116 [TBL] [Abstract][Full Text] [Related]
36. Dok-5 is involved in cardiomyocyte differentiation through PKB/FOXO3a pathway. Wen J; Xia Q; Wang C; Liu W; Chen Y; Gao J; Gong Y; Yin B; Ke Y; Qiang B; Yuan J; Peng X J Mol Cell Cardiol; 2009 Dec; 47(6):761-9. PubMed ID: 19800350 [TBL] [Abstract][Full Text] [Related]
37. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity. Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270 [TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. Wu W; Zou M; Brickley DR; Pew T; Conzen SD Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749 [TBL] [Abstract][Full Text] [Related]
39. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression. Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980 [TBL] [Abstract][Full Text] [Related]
40. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling. Zhang Z; Zhang T; Zhou Y; Wei X; Zhu J; Zhang J; Wang C Cell Physiol Biochem; 2015; 35(4):1643-53. PubMed ID: 25824462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]